ArticleBMC cancer2026

Glucose-transporter 1 (GLUT1) as a prognostic biomarker: evidence from 14,966 human tumors across 134 cancer types.

Seyma Büyücek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.